Status:
COMPLETED
Prenatal Corticosteroids and Antioxidants in Preterm Infants
Lead Sponsor:
Fundacion Para La Investigacion Hospital La Fe
Collaborating Sponsors:
University of Valencia
Carlos III Health Institute
Conditions:
Oxidative Stress
Eligibility:
All Genders
Brief Summary
Premature infants are highly susceptible to oxidative stress because of the immaturity of their antioxidant defense system. The use of prenatal glucocorticosteroids administered to the mother improves...
Detailed Description
This is an observational study recruiting extremely low gestational age neonates (\<28 weeks gestation) whose mothers received or not full scheduled prenatal glucocorticosteroids. Healthy term newly b...
Eligibility Criteria
Inclusion
- Gestational age \<28 weeks
- Registered used or not of prenatal glucocorticosteroids by the mother
Exclusion
- Use of pro-or-antioxidant drugs by the mother during gestation
- Major congenital malformations
- Prenatal inflammation (E.G.:chorioamnionitis)
- Chromosomopathies
- Uncertainty about gestational age
Key Trial Info
Start Date :
January 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2005
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT00791687
Start Date
January 1 2003
End Date
January 1 2005
Last Update
November 14 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Neonatology; University Hospital La Fe
Valencia, Valencia, Spain, 46009